Ru Zhou

5.5k total citations
113 papers, 3.8k citations indexed

About

Ru Zhou is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Ru Zhou has authored 113 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 28 papers in Immunology and 26 papers in Oncology. Recurrent topics in Ru Zhou's work include Natural Compounds in Disease Treatment (9 papers), Viral Infections and Immunology Research (8 papers) and CAR-T cell therapy research (7 papers). Ru Zhou is often cited by papers focused on Natural Compounds in Disease Treatment (9 papers), Viral Infections and Immunology Research (8 papers) and CAR-T cell therapy research (7 papers). Ru Zhou collaborates with scholars based in China, United States and United Kingdom. Ru Zhou's co-authors include Rachel R Caspi, Peter S. Dragovich, Thomas J. Prins, Jianping Zuo, Wei Tang, Pinku Mukherjee, Stephen T. Worland, Amy K. Patick, Shella A. Fuhrman and Phyllis B. Silver and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Ru Zhou

106 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ru Zhou China 34 1.2k 766 568 425 417 113 3.8k
Shuang Liu China 41 3.2k 2.6× 857 1.1× 882 1.6× 341 0.8× 139 0.3× 242 6.5k
Chunxia Chen China 34 2.1k 1.7× 1.3k 1.7× 1.0k 1.8× 138 0.3× 219 0.5× 183 5.1k
Koichí Matsumoto Japan 39 1.2k 1.0× 586 0.8× 329 0.6× 213 0.5× 443 1.1× 248 5.1k
Frans A. Kuypers United States 55 2.7k 2.2× 767 1.0× 222 0.4× 272 0.6× 229 0.5× 207 8.6k
Hong Cao China 41 1.9k 1.5× 629 0.8× 236 0.4× 248 0.6× 284 0.7× 205 5.2k
Alessandro Allegra Italy 37 1.9k 1.6× 710 0.9× 985 1.7× 91 0.2× 131 0.3× 263 5.0k
Michael J. Evans United States 48 2.6k 2.1× 477 0.6× 973 1.7× 573 1.3× 92 0.2× 186 9.2k
Vijay K. Singh United States 46 2.0k 1.6× 1.1k 1.4× 797 1.4× 252 0.6× 93 0.2× 234 6.6k
Hui‐Ling Chen Taiwan 38 1.9k 1.5× 423 0.6× 627 1.1× 240 0.6× 80 0.2× 167 4.6k
Nobuo Yamaguchi Japan 31 1.2k 0.9× 446 0.6× 519 0.9× 67 0.2× 281 0.7× 223 3.8k

Countries citing papers authored by Ru Zhou

Since Specialization
Citations

This map shows the geographic impact of Ru Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ru Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ru Zhou more than expected).

Fields of papers citing papers by Ru Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ru Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ru Zhou. The network helps show where Ru Zhou may publish in the future.

Co-authorship network of co-authors of Ru Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Ru Zhou. A scholar is included among the top collaborators of Ru Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ru Zhou. Ru Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zeng, Hong, Hai Guo, Ru Zhou, et al.. (2025). Effect of phase structure on the electrical properties of BiFeO 3 –BaTiO 3 -based ferroelectric ceramics. Journal of Advanced Dielectrics. 15(6). 1 indexed citations
2.
Zhou, Ru, Dan Wang, Hanwei Zhang, et al.. (2025). Vision techniques for anatomical structures in laparoscopic surgery: a comprehensive review. Frontiers in Surgery. 12. 1557153–1557153.
3.
4.
Yu, Xuecheng, Xin Wang, Fan Xu, et al.. (2024). Mir-615-3p promotes osteosarcoma progression via the SESN2/AMPK/mTOR pathway. Cancer Cell International. 24(1). 411–411. 2 indexed citations
5.
Qin, Bing, Ru Zhou, Xingxing Wang, et al.. (2024). Angiogenic and Fibrogenic Dual-effect of Gremlin1 on Proliferative Diabetic Retinopathy. International Journal of Biological Sciences. 20(3). 897–915. 3 indexed citations
6.
7.
Bose, Mukulika, et al.. (2022). Targeting tumor-associated MUC1 overcomes anoikis-resistance in pancreatic cancer. Translational research. 253. 41–56. 47 indexed citations
8.
Zhang, Jing, et al.. (2021). Human cell polyploidization: The good and the evil. Seminars in Cancer Biology. 81. 54–63. 35 indexed citations
9.
Kang, Taeho, Gary M. Gallego, Sajiv K. Nair, et al.. (2020). Multifaceted Substrate–Ligand Interactions Promote the Copper-Catalyzed Hydroboration of Benzylidenecyclobutanes and Related Compounds. ACS Catalysis. 10(21). 13075–13083. 29 indexed citations
10.
Yazdanifar, Mahboubeh, Ru Zhou, Priyanka Grover, et al.. (2019). Overcoming Immunological Resistance Enhances the Efficacy of a Novel Anti-tMUC1-CAR T Cell Treatment against Pancreatic Ductal Adenocarcinoma. Cells. 8(9). 1070–1070. 49 indexed citations
11.
Yu, Shentong, Ru Zhou, Tong Yang, et al.. (2019). Hypoxia promotes colorectal cancer cell migration and invasion in a SIRT1-dependent manner. Cancer Cell International. 19(1). 116–116. 31 indexed citations
12.
Moore, Laura J., Lopamudra Das Roy, Ru Zhou, et al.. (2016). Antibody-Guided In Vivo Imaging for Early Detection of Mammary Gland Tumors. Translational Oncology. 9(4). 295–305. 25 indexed citations
13.
Zhang, Jing, Xiaoqin Liang, Yingmei Wang, et al.. (2015). Anaplastic lymphoma kinase-positive anaplastic large-cell lymphoma with involvement of the urinary bladder: a case report and review of literature. OncoTargets and Therapy. 8. 1143–1143. 1 indexed citations
14.
Zhou, Ru, et al.. (2011). Estriol has different effects from 17β-estradiol in modulating mouse splenocyte function under inflammatory conditions. Journal of Immunotoxicology. 8(4). 346–358. 7 indexed citations
15.
Zhou, Ru, Masayuki Fukui, Hye Joung Choi, & Bao Ting Zhu. (2009). Induction of a reversible, non‐cytotoxic S‐phase delay by resveratrol: implications for a mechanism of lifespan prolongation and cancer protection. British Journal of Pharmacology. 158(2). 462–474. 26 indexed citations
16.
Pfefferkorn, Jeffrey A., Jihong Lou, Martha L. Minich, et al.. (2009). Pyridones as glucokinase activators: Identification of a unique metabolic liability of the 4-sulfonyl-2-pyridone heterocycle. Bioorganic & Medicinal Chemistry Letters. 19(12). 3247–3252. 66 indexed citations
17.
Ren, Yongxin, Ru Zhou, Wei Tang, et al.. (2007). (5R)-5-hydroxytriptolide (LLDT-8) protects against bleomycin-induced lung fibrosis in mice. Acta Pharmacologica Sinica. 28(4). 518–525. 30 indexed citations
18.
Tang, Wei, Yang Yang, Fan Zhang, et al.. (2005). Prevention of graft-versus-host disease by a novel immunosuppressant, (5R)-5-hydroxytriptolide (LLDT-8), through expansion of regulatory T cells. International Immunopharmacology. 5(13-14). 1904–1913. 34 indexed citations
19.
Zhou, Ru, et al.. (2005). Inhibition of Inducible Nitric-Oxide Synthase Expression by (5 R)-5-Hydroxytriptolide in Interferon-γ- and Bacterial Lipopolysaccharide-Stimulated Macrophages. Journal of Pharmacology and Experimental Therapeutics. 316(1). 121–128. 34 indexed citations
20.
Dragovich, Peter S., Stephen E. Webber, Thomas J. Prins, et al.. (1999). Structure-based design of irreversible, tripeptidyl human rhinovirus 3C protease inhibitors containing N-methyl amino acids. Bioorganic & Medicinal Chemistry Letters. 9(15). 2189–2194. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shuang Liu Breakdown of academic impact, for papers by Chunxia Chen Breakdown of academic impact, for papers by Koichí Matsumoto Breakdown of academic impact, for papers by Frans A. Kuypers Breakdown of academic impact, for papers by Hong Cao Breakdown of academic impact, for papers by Alessandro Allegra Breakdown of academic impact, for papers by Michael J. Evans Breakdown of academic impact, for papers by Vijay K. Singh Breakdown of academic impact, for papers by Hui‐Ling Chen Breakdown of academic impact, for papers by Nobuo Yamaguchi
Rankless by CCL
2026